9,289 research outputs found

    Jaffe A. J., Froomkin Joseph — Technology and Jobs

    No full text
    Daric Jean. Jaffe A. J., Froomkin Joseph — Technology and Jobs. In: Population, 25ᵉ année, n°1, 1970. pp. 216-217

    Henri Temianka Correspondence; (jaffe)

    No full text
    This collection contains material pertaining to the life, career, and activities of Henri Temianka, violin virtuoso, conductor, music teacher, and author. Materials include correspondence, concert programs and flyers, music scores, photographs, and books.https://digitalcommons.chapman.edu/temianka_correspondence/3789/thumbnail.jp

    Jaffe–Feldman–Varga: A tudás átterjedésének keresése

    No full text
    A régi növekedési elméletről az endogén technikai változásra való áttérés az 1990-es években szükségessé tette a technikai változás, a tudásterjedés és a gazdasági növekedés szerepének újragondolását. A tudástermelési függvényt használva Adam Jaffe volt az első, aki azonosította, hogy az egyetemi kutatás milyen mértékben hat a kereskedelmi tevékenységekre. Maryann Feldman kiterjesztette a tudástermelési függvényt az innovatív tevékenységekre, és beépítette a regionális tudás-­infrastruktúra szempontjait. Varga Attila a Jaffe–Feldman-féle megközelítést azzal bővítette ki, hogy a helyi tudásterjedés pontosabb mérésére összpontosított városi szinten. Varga a tudásterjedés kérdését explicit térbeli ökonometriai perspektívából közelítette meg. A Jaffe–Feldman–Varga-féle megközelítés a tudásterjedés technológiai változásban betöltött szerepének megértését segíti elő

    Market Value and Patent Citations: A First Look

    No full text
    As patent data become more available in machine-readable form, an increasing number of researchers have begun to use measures based on patents and their citations as indicators of technological output and information flow. This paper explores the economic meaning of these citation-based patent measures using the financial market valuation of the firms that own the patents. Using a new and comprehensive dataset containing over 4800 U. S. Manufacturing firms and their patenting activity for the past 30 years, we explore the contributions of R&D spending, patents, and citation-weighted patents to measures of Tobin's Q for the firms. We find that citation-weighted patent stocks are more highly correlated with market value than patent stocks themselves and that this fact is due mainly to the high valuation placed on firms that hold very highly cited patents.

    Creatinine determination according to Jaffe: what does it stand for?

    No full text
    In 1886, Max Jaffe discovered a reaction of creatinine with picric acid in an alkaline environment. Although the manuscript describes the nature of a precipitate and does not deal with an analytical assay, Jaffe's landmark paper elucidated the basic principles of the creatinine determination method (originally developed by Otto Folin), which became immensely popular and has easily withstood the test of time. Despite the advent of the enzymatic creatinine analysis, the analytical method is still popular due to its simplicity and low cost. As there is no standard recipe for the ‘Jaffe’ method, much methodological variation has occurred over time. This lack of methodological standardization implies that even in the 21st century, improving the interchangeability of Jaffe results is still an issue

    “Excavating AI” Re-excavated: Debunking a Fallacious Account of the JAFFE Dataset

    No full text
    Twenty-five years ago, my colleagues Miyuki Kamachi and Jiro Gyoba and I designed and photographed JAFFE, a set of facial expression images intended for use in a study of face perception. In 2019, without seeking permission or informing us, Kate Crawford and Trevor Paglen exhibited JAFFE in two widely publicized art shows. In addition, they published a nonfactual account of the images in the essay “Excavating AI: The Politics of Images in Machine Learning Training Sets.” The present article recounts the creation of the JAFFE dataset and unravels each of Crawford and Paglen’s fallacious statements. I also discuss JAFFE more broadly in connection with research on facial expression, affective computing, and human-computer interaction

    Gordon, Abe J., and Joel Levine with General Abraham Haffe, photograph

    No full text
    This undated, black and white photograph was taken by Commerical Photographic. Pictured from left to right are, Gordon I. Levine, General Abraham Jaffe, Abe J. Levine, and Joel A. Levine. It's location is undetermined

    Verification of the analytical characteristics of troponin assays in the laboratory : A how to guide

    No full text
    It is important that both laboratory staff performing troponin measurement and clinicians who interpret troponin results should 'know their routine laboratory's troponin assay' and its performance characteristics. International quality systems established by the International Organization for Standardization (ISO) and accepted by clinical laboratories worldwide require the verification of a new method. As a minimum, a troponin method must be verified as showing 'fitness for purpose' before being used to produce analytical data for patient care. The analytical performance characteristics of troponin assays that require an initial verification include imprecision and limit of quantitation. Validation of the upper reference limit that has been established by the manufacturer is also highly desirable, if possible. If the assay is replacing a previous assay, a method comparison and, if possible, an audit of performance should also be done. Investigation of other characteristics such as limit of blank, limit of detection, interferences and linearity is optional and depends on a laboratory's situation and the availability of resources to do this work. The monitoring of assay performance requires use of appropriate Intemal Quality Controls to assess the assay traceability (bias) and imprecision, and participation in an External Quality Assessinent Scheme to evaluate the assay accuracy and laboratory performance. In addition, the introduction of newer more sensitive troponin assays may require clinical validation in collaboration with local cardiology units and emergency medicine departments, and auditing of the impact of implementation of these more analytically sensitive assays. The following chapter provides a 'how to' guide to clinical laboratories for the verification and monitoring of the analytical performance of troponin assays
    corecore